Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?
Kumaresan SandrasegaranEnming CuiReem ElkadyPauley GasparisGitasree BorthakurMark TannSuthat LiangpunsakulPublished in: European radiology (2018)
• Gadoxetate parameters may identify cirrhotic patients at risk of adverse events. • Gadoxetate parameters usually show superior predictive values compared to clinical scores. • CES 20 score is associated with risk of mortality within 2 years.